This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Sk Chemicals Co., Ltd., Tiumbio Co., Ltd.. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yongin-si, KR (2014 - 2015)
- Gyeonggi-do, KR (2018)
Company Filing History:
Years Active: 2014-2018
Title: Yoon-Jung Lee: Innovator in Pharmaceutical Compounds
Introduction
Yoon-Jung Lee is a notable inventor based in Yongin-si, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target glucocorticoid regulation.
Latest Patents
Yoon-Jung Lee holds two patents, showcasing her innovative work. Her latest patents include picolinamide and pyrimidine-4-carboxamide compounds, which are designed for preventing, regulating, and treating diseases related to glucocorticoid regulation. These compounds act as selective inhibitors of the human-derived 11β-HSD1 enzyme, making them valuable in addressing metabolic syndromes such as type 1 and type 2 diabetes, obesity, and hypertension. Additionally, she has developed a stable pharmaceutical composition containing docetaxel, which offers improved storage stability compared to conventional medications. This composition is prepared by dissolving docetaxel in distilled water with cyclodextrin and a water-soluble polymer, followed by lyophilization.
Career Highlights
Throughout her career, Yoon-Jung Lee has worked with reputable organizations, including Sk Chemicals Co., Ltd. and the Ewha University-Industry Collaboration Foundation. Her work has significantly impacted the pharmaceutical industry, particularly in the development of innovative treatments.
Collaborations
Yoon-Jung Lee has collaborated with notable individuals in her field, including Nam Ho Kim and Jin Young Lee. These collaborations have further enhanced her research and development efforts.
Conclusion
Yoon-Jung Lee's contributions to pharmaceutical innovations demonstrate her commitment to advancing medical science. Her patents reflect her expertise and dedication to improving health outcomes through innovative compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile